Brief: Gland Pharma Gets EIR From U.S. FDA For Company’S JNPC Facility, Visakhapatnam
24/06/2025 06:44
June 24 (Reuters) - Gland Pharma Ltd GLAD.NS: RECEIPT OF EIR FROM US FDA FOR COMPANY’S JNPC FACILITY, VISAKHAPATNAM Further company coverage: GLAD.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant